Presented September 6th, 2023 at the APSF Stoelting Conference 2023 on “Emerging Medical Technologies – A Patient Safety Perspective on Wearables, Big Data and Remote Care”
PRESENTATION MATERIALS
Acute Care and Wearable Technology – [PDF]
ABOUT THE SPEAKER(S)
Ashish Khanna, MD, MS, FCCP, FCCM, FASA
Ashish Khanna, MD, MS, FCCP, FCCM, FASA
Associate Professor of Anesthesiology
Wake Forest University
Dr. Ashish K Khanna is an associate professor of anesthesiology and vice-chair of research with the department of anesthesiology, section on critical care medicine at the Wake Forest University School of Medicine in Winston-Salem, NC. He is also a member of the Wake Center for Biomedical Informatics, a core faculty for the Center for Healthcare Innovation, and the Wake Forest Hypertension and Vascular Research Cardiovascular Science Center. He is the director for the Perioperative Outcomes and Informatics Collaborative (POIC) a large perioperative outcomes collaborative research program that is staffed with several research nurses, fellows, technicians, students, data scientists and administrative staff and is a center of excellence for clinical trials across specialties. In addition, he is a major regional director for the Outcomes Research Consortium.
Dr. Khanna is currently incoming chair for the American Society of Anesthesiologists (ASA) committee on critical care medicine, and also sits as a past chair for the abstract review subcommittee on critical care medicine and is a member of the educational track subcommittee for critical care medicine. He is heavily engaged with the Society of Critical Care Medicine (SCCM) and currently past- chair for the research section, is on the steering committee for the anesthesiology section and vice-chair for the Discovery research network, along with being a program co-chair for the 2023 congress. He is on the board of directors for the Society of Critical Care Anesthesiologists (SOCCA). His research interests include prediction of post-operative respiratory and cardiac events on the regular nursing floor, use of large datasets for perioperative outcomes research, effects of hypotension in critically ill patients and use of novel vasopressors in shock states in the ICU. Dr. Khanna has more than a 150 peer reviewed papers, two dozen book chapters, editorials, invited non-peer reviewed articles, and has been invited to talk about this work at prestigious national and international forums. From 2015-2017 Dr. Khanna led the Angiotensin II in High Output Shock (ATHOS3) trial and the publication of this work in the NEJM. This work translated to the US FDA approval of this novel vasopressor for management of broad indications of high output shock and is currently being used across the United States in critically ill patients. He is a founding member for the BrainX group, which collaborates, educates, and conducts research, helps with innovation and development of new ideas centered around big data analytics.
